508 related articles for article (PubMed ID: 29743377)
1. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
2. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
3. Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
Meier K; Jaguva Vasudevan AA; Zhang Z; Bähr A; Kochs G; Häussinger D; Münk C
Virology; 2018 Oct; 523():52-63. PubMed ID: 30081309
[TBL] [Abstract][Full Text] [Related]
4. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
5. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
6. Host and viral determinants of Mx2 antiretroviral activity.
Busnadiego I; Kane M; Rihn SJ; Preugschas HF; Hughes J; Blanco-Melo D; Strouvelle VP; Zang TM; Willett BJ; Boutell C; Bieniasz PD; Wilson SJ
J Virol; 2014 Jul; 88(14):7738-52. PubMed ID: 24760893
[TBL] [Abstract][Full Text] [Related]
7. Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.
Schulte B; Buffone C; Opp S; Di Nunzio F; De Souza Aranha Vieira DA; Brandariz-Nuñez A; Diaz-Griffero F
J Virol; 2015 Aug; 89(16):8599-610. PubMed ID: 26063425
[TBL] [Abstract][Full Text] [Related]
8. Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.
Du C; Liu HF; Lin YZ; Wang XF; Ma J; Li YJ; Wang X; Zhou JH
Proteomics; 2015 Jun; 15(11):1843-58. PubMed ID: 25684102
[TBL] [Abstract][Full Text] [Related]
9. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
12. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
[TBL] [Abstract][Full Text] [Related]
13. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
[TBL] [Abstract][Full Text] [Related]
14. Host cell restriction factors of equine infectious anemia virus.
Wang XF; Zhang X; Ma W; Li J; Wang X
Virol Sin; 2023 Aug; 38(4):485-496. PubMed ID: 37419416
[TBL] [Abstract][Full Text] [Related]
15. Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism.
Lin YZ; Sun LK; Zhu DT; Hu Z; Wang XF; Du C; Wang YH; Wang XJ; Zhou JH
Virology; 2016 Aug; 495():112-21. PubMed ID: 27200480
[TBL] [Abstract][Full Text] [Related]
16. MX2 is an interferon-induced inhibitor of HIV-1 infection.
Kane M; Yadav SS; Bitzegeio J; Kutluay SB; Zang T; Wilson SJ; Schoggins JW; Rice CM; Yamashita M; Hatziioannou T; Bieniasz PD
Nature; 2013 Oct; 502(7472):563-6. PubMed ID: 24121441
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
Chen C; Li F; Montelaro RC
J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
[TBL] [Abstract][Full Text] [Related]
18. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
Steiner F; Pavlovic J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
[TBL] [Abstract][Full Text] [Related]
19. Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.
Buffone C; Schulte B; Opp S; Diaz-Griffero F
J Virol; 2015 Mar; 89(6):3285-94. PubMed ID: 25568212
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
Smith TA; Davis E; Carpenter S
J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]